NanoViricides Inc. (NNVC)

[leifsmith]

From Dr. Seymour - Thanks to Another_Voice_2 (on SI) 4/25/2015 10:25:35 AM

A Message From Dr. Seymour. Edited to leave out the individual who began the exchange.

He’s panicked

He is exactly the wrong person to be investing in a pre-clinical biotech company. He has no experience watching this sector and understanding the process of moving from pre-clinical to a clinical status . He doesn’t understand that, on the average, it takes 12-14 years to get a drug to market at an average cost of $2.55B (according to a Tufts University study)

Our plan is to do it in 10 years (next year) for $75M…and we have a stable of drugs that we will move into the marketplace at the rate of 1-2/year. A number of them have multi-billion dollar potential.

Take a look at Regeneron (REGN). Probably the finest scientific and management team in existence. They spent $1.2B over a 24 year period with multiple failures until they bought an eye drug that sold $1B last year

Their stock 20 years ago was $4/share and now it’s $480/share with a market cap of $50B

One drug…that’s all they have…we have a PLATFORM with the possibility of an infinite number of drugs with NO FAILURES

We have a plant, great scientists and enough money in the bank ($35M) to get the first one or two through the regulatory process.

That’s what experienced investors understand. Those inexperienced in this sector only look at the stock price and equate that with the progress of the company

I sympathize with the small investor who sees the value of their portfolio decreasing. That’s exactly the time to double down!

Biotech investing is nothing more than gambling

It takes confidence in the science and the management to remain invested

If both of those elements are not present, time to take one’s losses and get out!

Sincerely,

Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
[e-mail]
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange